Equitec Proprietary Markets’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Equitec Proprietary Markets’s Portfolio SURF Stock Details SURF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-20,198	Closed	-$17.6K	–	145
2023 Q2	$17.6K	Buy	+20,198	New	+$14.4K	0.01%	77

Equitec Proprietary Markets's SURF Position: Q3 2023 in Review

Equitec Proprietary Markets sold out of Surface Oncology, Inc. Common Stock (SURF) in Q3 2023, closing a stake of 20,198 shares — an estimated $17.6K sold.

Equitec Proprietary Markets first reported a position in SURF in Q2 2023 and held it in 1 quarter. The position peaked at $17.6K in Q2 2023. 0 funds tracked by Wall St. Rank hold SURF as of Q3 2023.

Equitec Proprietary Markets reported no remaining Surface Oncology, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Equitec Proprietary Markets sold 20,198 Surface Oncology, Inc. Common Stock shares in Q3 2023, an estimated $17.6K.
Equitec Proprietary Markets first reported a position in Surface Oncology, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Equitec Proprietary Markets's Surface Oncology, Inc. Common Stock position peaked at $17.6K in Q2 2023.
0 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q3 2023.

Based on Equitec Proprietary Markets's 13F filing for Q3 2023, filed 17 Oct 2023.